Valuation : Lead Data Inc.

Market Cap 539M 17.1M 14.71M 13.85M 12.62M 23.62M 1.63B 23.71M 164M 63.46M 829M 64.21M 62.81M 2.63B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 18.02M 15.51M 14.6M 13.31M 24.9M 1.72B 24.99M 173M 66.89M 874M 67.68M 66.21M 2.77B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 16/08/2022
Director of Finance/CFO - 09/06/2022
Corporate Officer/Principal - 09/06/2022
Director TitleAgeSince
Director/Board Member - 09/06/2019
Chairman - 16/08/2022
Director/Board Member - 09/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+13.33% 17.09M
-1.00%-0.62%+29.86%+19.07% 9.9B
-0.08%-1.37%+4.06%+0.21% 1.4B
-3.44%-4.60% - - 1.33B
-1.48%-3.51%-5.92%-15.52% 1.14B
-0.22%+7.92%+98.66%+61.43% 794M
-1.13%-1.47%-23.31%-53.74% 614M
-0.14%-0.14%-15.67%-11.65% 425M
0.00%-3.48%+89.61%+143.27% 419M
-0.24%-1.26%-6.44%+14.05% 223M
Average -1.76%-2.19%+18.98%+18.94% 1.63B
Weighted average by Cap. -1.07%+0.13%+25.98%+16.45%

Financials

2024 2025
Net sales 15.47M 491K 422K 398K 362K 678K 46.71M 681K 4.71M 1.82M 23.8M 1.84M 1.8M 75.39M 111M 3.51M 3.02M 2.85M 2.59M 4.85M 334M 4.87M 33.74M 13.04M 170M 13.19M 12.9M 540M
Net income -134M -4.25M -3.65M -3.44M -3.13M -5.87M -404M -5.89M -40.78M -15.76M -206M -15.94M -15.6M -652M -44.02M -1.4M -1.2M -1.13M -1.03M -1.93M -133M -1.94M -13.42M -5.19M -67.73M -5.25M -5.13M -215M
Net Debt -16.95M -538K -463K -436K -397K -743K -51.2M -746K -5.17M -2M -26.08M -2.02M -1.98M -82.64M 29.12M 924K 795K 749K 682K 1.28M 87.94M 1.28M 8.87M 3.43M 44.8M 3.47M 3.39M 142M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!